AI Biotechnology LLC

10% owner at VYNE Therapeutics Inc. · on record since Nov 13, 2023
10% owner at Upstream Bio, Inc. · on record since Oct 17, 2024
10% owner at Zura Bio Ltd · on record since May 28, 2025
10% owner at OnKure Therapeutics, Inc. · on record since Apr 7, 2026
10% owner at Hemab Therapeutics Holdings, Inc. · on record since May 14, 2026
10% owner at Verona Pharma plc · on record since Aug 17, 2022

Insider trading activity of AI Biotechnology LLC

No transactions on record for AI Biotechnology LLC.

Track record of AI Biotechnology LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of AI Biotechnology LLC

Co-insiders of AI Biotechnology LLC

Access Industries Holdings LLCHemab Therapeutics Holdings, Inc. +5
ACCESS INDUSTRIES MANAGEMENT, LLCHemab Therapeutics Holdings, Inc. +5
Blavatnik LenHemab Therapeutics Holdings, Inc. +5
BASKETT FORESTOnKure Therapeutics, Inc. +1
Florence Anthony A. Jr.OnKure Therapeutics, Inc. +1
Makhzoumi MohamadOnKure Therapeutics, Inc. +1
MAKOWER JOSHUAOnKure Therapeutics, Inc. +1
Novo A/SHemab Therapeutics Holdings, Inc. +1
ORBIMED ADVISORS LLCUpstream Bio, Inc. +1
Ratcliffe LiamOnKure Therapeutics, Inc. +1
SANDELL SCOTT DOnKure Therapeutics, Inc. +1
Sonsini Peter W.OnKure Therapeutics, Inc. +1
ACKERMANN CHRISTINAVerona Pharma plc
ACORN BIOVENTURES 2, L.P.OnKure Therapeutics, Inc.
ACORN BIOVENTURES, L.P.OnKure Therapeutics, Inc.
Acorn Capital Advisors GP 2, LLCOnKure Therapeutics, Inc.
ACORN CAPITAL ADVISORS GP, LLCOnKure Therapeutics, Inc.
Agresta SamuelOnKure Therapeutics, Inc.
AI DEN-MAB LLCHemab Therapeutics Holdings, Inc.
AI Upstream LLCUpstream Bio, Inc.
Ambrose AllisonUpstream Bio, Inc.
Athanor CapitalZura Bio Ltd
Athanor Capital, LPZura Bio Ltd
Austwick MichaelVerona Pharma plc
Badial Verender S.Zura Bio Ltd
Bain LindaHemab Therapeutics Holdings, Inc.
BALL KRISTINE MVYNE Therapeutics Inc.
BARBARI SHARON SURREYVYNE Therapeutics Inc.
BARCLAYS PLCZura Bio Ltd
Basta Steven LVYNE Therapeutics Inc.
Becker Daniel J.Zura Bio Ltd
Beckman DaniellaUpstream Bio, Inc.
Behrndt-Eriksen Mads NikolajHemab Therapeutics Holdings, Inc.
BERNS PAUL LVYNE Therapeutics Inc.
Blunt Roshawn A.OnKure Therapeutics, Inc.
Borowski ChristineVYNE Therapeutics Inc.
Brady James AloysiusVerona Pharma plc
Bright RexVYNE Therapeutics Inc.
Bruno Anthony DVYNE Therapeutics Inc.
Cabell ChristopherZura Bio Ltd
Cardon LonOnKure Therapeutics, Inc.
Carruthers R MichaelOnKure Therapeutics, Inc.
CHA ALBERTVYNE Therapeutics Inc.
Chen BihuaOnKure Therapeutics, Inc.
Chimovits ErezUpstream Bio, Inc.
CMEA Ventures VII LPVYNE Therapeutics Inc.
CMEA VENTURES VII (PARALLEL) LPVYNE Therapeutics Inc.
Collier David JVYNE Therapeutics Inc.
Cormorant Asset Management, LPOnKure Therapeutics, Inc.
Cormorant Global Healthcare Master Fund, LPOnKure Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →